**This article has been corrected:** For purposes of clarity, Figure 2B has been updated. In the corrected Figure 2B, a clear vertical line was added to each band, as well as two new labels ("exogenous synthetic" and "cell component") in the bottom of the figure in order to more clearly point out that the left side of the line represents exogenous synthetic AMF, while the right side is cell component. In addition, the figure legend of Figure 2B has been corrected to read: "B. Top, Immunoblot analysis for AMF protein and β-actin expression. The band on the left side of the vertical line were exogenous synthetic, and the band on the right side were cell component. Bottom, quantification analysis of AMF expression. AMF cytokine itself was used as positive control."

There is also a correction to Figure 4. During figure assembly, the Figure 4B was pasted twice (classified by concentration) and the Figure 4C (classified by time) was omitted. The corrected Figure 4, obtained using original data, is shown below. The authors declare that these corrections do not change the results or conclusions of this paper.
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